Health Trials

Relapsed or Refractory Hodgkin Lymphoma

1

Review clinical trials related to Relapsed or Refractory Hodgkin Lymphoma. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

The purpose of this study is to test any good and bad effects of the study drug, pembrolizumab, in combination with GVD in the treatment of Hodgkin lymphoma.

Participants needed: 257
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Memorial Sloan Kettering Cancer CenterUpdated: Jun 29, 2026Locations: 10
Eligibility criteria

Histologic diagnosis of classical Hodgkin's lymphoma. Primary refractory or rela... [+28]

Received more than 1 prior treatment (combined modality therapy represents 1 tre... [+14]

Read more